SynthesisBreast cancer research and treatment2020

Evaluating the clinical effectiveness and safety of various HER2-targeted regimens after prior taxane/trastuzumab in patients with previously treated, unresectable, or metastatic HER2-positive breast cancer: a systematic review and network meta-analysis.

Noman Paracha et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.